CONSERVATIVE TREATMENT OF CHRONIC RHINOSINUSITIS IN CHILDREN WITH CYSTIC FIBROSIS

Authors

  • Makhmudova Saodat Kurbonbekovna First-Year Basic Doctoral (PhD) Student, Department of Otorhinolaryngology No. 1, Samarkand State Medical University.
  • Khushvakova Nilyufar Juraqulova Head of the Department of Otorhinolaryngology No. 1, Samarkand State Medical University, Doctor of Medical Sciences, Professor.
  • Khamrakulova Nargiza Orzuyevna Associate Professor, Department of Otorhinolaryngology No. 1, Samarkand State Medical University, Doctor of Medical Sciences.

Keywords:

Keywords: Cystic fibrosis, chronic rhinosinusitis, children, conservative treatment, mucociliary clearance, nasal irrigation, mucolytic therapy.

Abstract

Abstract: This thesis discusses the conservative treatment of chronic rhinosinusitis in children with cystic fibrosis. In cystic fibrosis, the production of thick and viscous secretions may impair mucociliary clearance and contribute to chronic inflammation of the nasal cavity and paranasal sinuses. The main goals of conservative treatment are to reduce sinonasal symptoms, improve mucus clearance, and enhance the patient’s quality of life. Nasal saline irrigation, intranasal medications, and, in selected cases, mucolytic agents are considered important components of treatment. Regular clinical assessment of treatment effectiveness and an individualized therapeutic approach are essential for optimal management.

References

1.Mainz J. G., Schien C., Schiller I., et al. Sinonasal inhalation of dornase alfa administered by vibrating aerosol to cystic fibrosis patients: a double-blind placebo-controlled cross-over trial // Journal of Cystic Fibrosis. 2014. Vol. 13, № 4. P. 461–470.

2.Mainz J. G., Schiller I., Ritschel C., et al. Sinonasal inhalation of dornase alfa in cystic fibrosis: a double-blind placebo-controlled cross-over pilot trial // Auris Nasus Larynx. 2011. Vol. 38, № 2. P. 220–227

3.Mainz J. G., Schiller I., Schädlich K., et al. Sinonasal inhalation of isotonic versus hypertonic saline (6.0%) in cystic fibrosis patients with chronic rhinosinusitis: results of a multicenter, prospective, randomized, double-blind, controlled trial // Journal of Cystic Fibrosis. 2016. Vol. 15.

4.Ozturk S., et al. Treatment of chronic rhinosinusitis with dornase alfa in patients with cystic fibrosis: a systematic review // International Forum of Allergy & Rhinology. 2018.

5.Fokkens W. J., Lund V. J., Hopkins C., et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020 // Rhinology. 2020. Vol. 58, Suppl. 29. — P. 1–464.

Downloads

Published

2026-08-26

Conference Proceedings Volume

Section

Articles

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.